| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.005 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |